4 years ago
VIR
AnalystsJoseph StringerJoseph Stringer's Stock Forecasts
AnalystsJoseph Stringer
Analyst Ranking
Top 2%
#66 out of 5296 analysts
Average Return
+31.74%
Win Rate
46%154 out of 332
Risk vs Reward
Poor
Good
Joseph Stringer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,195.38% | $17.09 | $221.38 | 2025-04-09 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +835.67% | $23.66 | $221.38 | 2025-03-06 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +820.50% | $24.05 | $221.38 | 2025-06-03 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-22 - 2026-01-06 | Buy |
Avidity Biosciences IncRNAM | +454.80% | $7.81 | $43.33 | 2023-11-28 - 2024-11-27 | Buy |
Joseph Stringer Analyst Color
Get additional color on Joseph Stringer's coverage of popular stocks
Joseph Stringer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Shattuck Labs IncSTTK | 1 | Buy | $17.00 | +244.13% | Maintains | 5 days ago |
Bioage Labs IncBIOA | 1 | Buy | $50.00 | +177.16% | Initiates Coverage On | 3 months ago |
Ionis Pharmaceuticals IncIONS | 27 | Buy | $105.00 | +43.30% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 23 | Buy | $40.00 | +34.14% | Maintains | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 31 | Buy | $130.00 | +47.09% | Maintains | 3 months ago |
Vir Biotechnology IncVIR | 20 | Buy | $18.00 | +109.06% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 5 | Buy | $170.00 | +35.36% | Reiterates | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 25 | Buy | $510.00 | +80.31% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 20 | Buy | $28.00 | -31.76% | Maintains | 5 months ago |
Vaxcyte IncPCVX | 18 | Buy | $110.00 | +131.77% | Maintains | 5 months ago |
Cidara Therapeutics IncCDTX | 15 | Buy | $135.00 | -39.02% | Maintains | 7 months ago |
Avidity Biosciences IncRNAM | 19 | Hold | $65.00 | +340.68% | Downgrades | 8 months ago |
Phathom Pharmaceuticals IncPHAT | 51 | Buy | $28.00 | N/A | Maintains | a year ago |
Inozyme Pharma IncINZY | 20 | Hold | $12.00 | N/A | Downgrades | a year ago |
Annexon IncANNX | 17 | Buy | $11.00 | N/A | Maintains | a year ago |
Pliant Therapeutics IncPLRX | 17 | Hold | $10.00 | N/A | Downgrades | a year ago |
Tvardi Therapeutics IncTVRD | 14 | Buy | $60.00 | N/A | Reiterates | 2 years ago |
Acadia Pharmaceuticals IncACAD | 4 | Buy | $37.00 | N/A | Upgrades | 2 years ago |
Intercept Pharmaceuticals IncICPT | 4 | Buy | $26.00 | N/A | Maintains | 3 years ago |
Zealand Pharma AZEAL | 1 | Buy | $32.00 | N/A | Maintains | 4 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Theravance Biopharma IncTBPH | 2 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.